We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
5 hedge funds and large institutions have $1.12M invested in Plus Therapeutics in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
17% more capital invested
Capital invested by funds: $952K → $1.12M (+$164K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$420K |
| 2 |
Jane Street
New York
|
+$70.1K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$70.1K |
| 2 |
Renaissance Technologies
New York
|
-$43K |
| 3 |
Bank of New York Mellon
New York
|
-$11K |
| 4 |
VF
Virtu Financial
New York
|
-$10K |
| 5 |
UB
UMB Bank
Kansas City,
Missouri
|
-$7K |
